LATEST
Joshua Wong jailed for 10 years over bid to instigate sanctions on Beijing, Hong Kong✦Review: शानदार VFX-इमोशन, दिल में उतरी 'रामायण', कहां रही कमी?✦Oil and data centre stocks sink after US midterms✦India's markets regulator approves Coal India unit Mahanadi Coalfields IPO✦Turkiye’s solar boom shines ahead of a UN climate summit but coal and other fossil fuels loom large✦
Thu, Nov 5, 2026
Loading weather...
Markets

Revolution Medicines Reports Third Quarter 2026 Financial Results and RASONQUE Launch

Revolution Medicines, Inc. announced its financial results for the quarter ended September 30, 2026, highlighted by the ...

By Dhallo News · November 5, 2026 at 7:29 AM IST

Revolution Medicines, Inc. announced its financial results for the quarter ended September 30, 2026, highlighted by the U.S. Food and Drug Administration approval and commercial launch of RASONQUE (daraxonrasib) on August 26, 2026. RASONQUE is approved for adult patients with met

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Thai Stock Market Tipped To Open In The Green

(RTTNews) - The Thai stock market on Wednesday ended the six-day losing streak i...

Read Article »

Montrose Environmental Group, Inc. Reports Third Quarter 2026 Results and Continues Strategic Review

Montrose Environmental Group, Inc., filing as Onterris, Inc., reported its finan...

Read Article »

Accuray Reports Fiscal 2027 First Quarter Financial Results

Accuray Incorporated reported financial results for the first quarter ended Sept...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.